Insights Archive

This report highlights analysis and key trends in the Robotic Assisted Surgery (RAS) Landscape. Included are development stage and funding status of RAS platforms in key segments, including surgical platforms and positioning/navigation-enabled platforms, as well as global market size, market trends, and healthcare investments.

This report provides a review of revenue growth for public companies in FSI’s Life Science Tools and Diagnostics segments from 2019 – 2023 as well as LS Tools and Dx investments and exits:

- Revenue performance of public companies in life science tools (including bioprocessing, diversified, and omics-related segments) and diagnostics (including genetic, cancer, and diversified IVD segments)
- Overview of VC investments, M&A, and IPOs in LS Tools and Dx
- Preview for upcoming Precision Medicine in Neuroscience report

This report analyzes revenue growth and investment trends across key Digital Health segments and stakeholders (including Payers, the Big Four Tech and Top MedTech Companies). The Spotlight is Value-based Care, A Digital Health Proving Ground, which highlights how Digital Health can be used to bridge gaps and drive outcomes.

Point-of-Care Molecular Diagnostics
GLP-1 Agonists and Cardiac Procedures
Digital Health – Specialty Telehealth
Bioprocessing Quality Control
Clinical Lab Services
Health System Innovation Group
CRO Services for Biosimilars Development
Clinical Research Organization
Multi-indication Surgical Robotic
Breast Localization and Lymphatic Mapping
Pharma Commercialization

Prostate Biopsy and Mapping
Augmented Reality Surgical Navigation 
Bioprocessing Quality Control
Endoluminal Robotics
Academic Medical Center
Enteral Feeding
Intraoperative Molecular Imaging
Medical Device Contract Manufacturing
Clinical Research Organization

Key Digital Health trends and a spotlight on Surgery: The Intersection of Digital Health / AI and Medtech. Investments in Digital Health (Medtech, the Big Four Tech and Payers). Analysis of Digital Health VC investments, M&A and IPOs.

Robotic Surgery
Hypoglycemia
Sacroiliac Joint Pain
Pharma Commercialization Services
Academic Medical Center
Clinical Research Organization
Health Insurance TPA
Medical Legal Regulatory (MLR) Consulting

Chronic Limb Threatening Ischemia
Pharma Commercialization Services
Intraoperative Molecular Imaging
Laparoscopic Surgery
Smart Abdominal Binder
Digital Health – Remote Patient Monitoring
Protein Characterization
Clinical Research Organization
Senior Living

This report provides a review of revenue performance of public companies in FSI’s Digital Health segments in 2022 as compared to previous years. Inside you will find FSI’s view of key trends from leading Digital Health companies and those investing in Digital Health (Medtech, the Big Four Tech, and Payors), as well as analysis of Digital Health VC investments, M&A, and IPOs

This report provides a review of revenue growth for public companies in FSI’s Life Science Tools and Diagnostics segments in 2022 as well as US investments and exits

This report provides a review of revenue growth for public companies in FSI’s Medtech segments in H2 2022 as well as US Medtech investments and exits

This report highlights FSI's Peripheral Vascular (PV) Device Review. Inside you will find the following:

- Revenue performance of key public companies, as well as peripheral vascular M&A and investments through 2022
- FSI’s view of key trends from leading companies in the PV space and those investing in peripheral vascular - devices
- Analysis of VC investments in select PV device segments, as well as M&A activity and IPOs

Microbiome Consumables and Services
Pulmonary Testing
Clinical Research Organization
Sleep Apnea Device
Oncology CRO
Pharma Clinical Trial Logistics
Academic Medical Center
Pharma Commercialization Services
Digital Health Staffing Solution
Clinical Research Organization
Heath System Innovation Group
Academic Medical Center
Women's Health
Novel Surgical Device Diligence
Home Care Digital Health Solution

This report highlights FSI's Cardiovascular Device Review of 2022. Inside you will find the following:

- Revenue performance of key public companies, as well as cardiovascular M&A and investments through 2022 
- FSI’s view of key trends from leading cardiovascular device companies and those investing in cardiovascular devices  
- Analysis of VC investments in select cardiovascular device segments, as well as M&A activity and IPOs

This report highlights the analysis of the Robotic Assisted Surgery (RAS) Landscape in 2022. Inside you will find the following:

- FSI’s unique framework used to analyze 128 RAS platforms
- Product development stage and funding status of 110 RAS companies
- Key trends from medtech executives and hospital perspective along with
challenges and opportunities for companies and investors
- Analysis of VC investments and M&A in RAS

This report highlights performance of the Digital Health segment in the first half of 2022 as compared to previous years, as well as investments and exits.
Included are public company revenue performance in key segments such as Telehealth and Healthcare IT, as well as analyses of Digital Health VC investments, M&A, and IPOs.

FSI's views on investments in the DCT space, regulatory trends, and applicability by therapeutic area shed light on how this emerging approach to clinical development will be adopted by industry.

This report provides a review of revenue growth for public companies in FSI’s Medtech segments from 2019 – H1 2022
as well as US Medtech investments and exits. Inside you will find:
- Revenue performance of public companies in key segments such as cardiovascular / peripheral vascular,
diagnostics, life science tools, orthopedics, and diversified companies
- Overview of US VC investments, M&A, and IPOs in medical devices/supplies and diagnostics/life science tools

Life Science Tools
Respiratory Devices
FemTech
Laser Ablation
Medical Imaging
Health System Pharmacy
Molecular Diagnostics
Bioprocessing
Pharma Sales
Gynecologic Devices
Health System Cost Cycle Management
Senior Living

Prostate Cancer
Intraoperative Diagnostics
Clinical Research Organization
Renal Replacement Therapy
Medical Device Reprocessing
Trigeminal Neuralgia
Innovation Banking
Neurosurgical Devices
Electric Vehicle Charging Infrastructure